Search

Your search keyword '"Tang, W.H. Wilson"' showing total 18 results
Start Over Author "Tang, W.H. Wilson" Journal american heart journal
18 results on '"Tang, W.H. Wilson"'

1. Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy

Author

Januzzi, James L., Jr, Butler, Javed, Del Prato, Stefano, Ezekowitz, Justin A., Ibrahim, Nasrien E., Lam, Carolyn S.P., Lewis, Gregory D., Marwick, Thomas H., Rosenstock, Julio, Tang, W.H. Wilson, Zannad, Faiez, Lawson, Francesca, Perfetti, Riccardo, and Urbinati, Alessia

Published
2023
Full Text
View/download PDF

7. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy

Author

Tang, W.H. Wilson, Steinhubl, Steven R., Van Lente, Frederick, Brennan, Danielle, McErlean, Ellen, Maroo, Anjli, Francis, Gary S., and Topol, Eric J.

Subjects
Transluminal angioplasty -- Patient outcomes, Transluminal angioplasty -- Research, Cardiac patients -- Prognosis, Cardiac patients -- Research, Natriuretic peptides -- Analysis, Cardiac output -- Analysis, Health
Published
2007

8. Why do patients fail to receive [beta]-blockers for chronic heart failure over time? A 'real-world' single-center, 2-year follow-up experience of [beta]-blocker therapy in patients with chronic heart failure

Author

Parameswaran, Anoop C., Tang, W.H. Wilson, Francis, Gary S., Gupta, Ritesh, and Young, James B.

Subjects
Heart failure -- Care and treatment, Cardiac patients -- Care and treatment, Adrenergic beta blockers, Cardiovascular agents, Health
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ahj.2004.07.026 Byline: Anoop C. Parameswaran (a), W.H. Wilson Tang (b), Gary S. Francis (b), Ritesh Gupta (c), James B. Young (a)(b) Abstract: The longitudinal pattern of [beta]-blocker use in a heart-failure practice setting has not been explored. Previous studies have not specifically addressed the use of [beta]-blockers over time to determine the rate of use and reasons for discontinuation. The long-term compliance rate for [beta]-blocker drugs outside the context of a clinical trial has not been established. Author Affiliation: (a) Department of Medicine, Cleveland Clinic Foundation, Cleveland, Ohio (b) Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio (c) Division of Cardiovascular Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala Article History: Received 20 April 2004; Accepted 30 July 2004 Article Note: (miscellaneous) This project did not receive any financial support. Drs Tang and Francis are consultants for GlaxoSmithKline Pharmaceuticals; Dr Young is a consultant for AstraZeneca Pharmaceuticals.

Published
2005

9. Impact of angiotensin-converting enzyme gene polymorhism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure

Author

Tang, W.H. Wilson, Vagelos, Randall H., Yee, Yin-Gail, and Fowler, Michael B.

Subjects
Neurohormones -- Research, Heart failure -- Care and treatment, Heart failure -- Drug therapy, Heart failure -- Patient outcomes, Enalapril -- Dosage and administration, Enalapril -- Complications and side effects, Enalapril -- Genetic aspects, Enalaprilat -- Dosage and administration, Enalaprilat -- Complications and side effects, Enalaprilat -- Genetic aspects, Cardiac patients -- Case studies, Cardiac patients -- Genetic aspects, Angiotensin converting enzyme -- Genetic aspects, Health
Published
2004

13. Diuretic response in acute heart failure—an analysis from ASCEND-HF

Author

ter Maaten, Jozine M., primary, Dunning, Allison M., additional, Valente, Mattia A.E., additional, Damman, Kevin, additional, Ezekowitz, Justin A., additional, Califf, Robert M., additional, Starling, Randall C., additional, van der Meer, Peter, additional, O'Connor, Christopher M., additional, Schulte, Phillip J., additional, Testani, Jeffrey M., additional, Hernandez, Adrian F., additional, Tang, W.H. Wilson, additional, and Voors, Adriaan A., additional

Published
2015
Full Text
View/download PDF

16. Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors

Author

Steingart, Richard M., primary, Bakris, George L., additional, Chen, Helen X., additional, Chen, Ming-Hui, additional, Force, Thomas, additional, Ivy, S. Percy, additional, Leier, Carl V., additional, Liu, Glenn, additional, Lenihan, Daniel, additional, Lindenfeld, JoAnn, additional, Maitland, Michael L., additional, Remick, Scot C., additional, and Tang, W.H. Wilson, additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results